Advertisement

Oral Complications of Multiorgan Disorders

      Oral manifestations of multiorgan disorders may be the first clinical signs of systemic disease or may signify a new sign of established, recurrent, or refractory disease.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      References

        • Fahrner K.S.
        • Black C.C.
        • Gosselin B.J.
        Localized amyloidosis of the tongue: a review.
        Am J Otolaryngol. 2004; 25: 186-189
        • Glenner G.G.
        Amyloid deposits and amyloidosis: the beta-fibrilloses (second of two parts).
        N Engl J Med. 1980; 302: 1333-1343
        • Kaushik R.
        • Pushpanshu K.
        • Punyani S.R.
        Orofacial amyloidosis-unusual presentation of a rare condition: a case report.
        Spec Care Dentist. 2016; 36: 104-107
        • Aono J.
        • Yamagata K.
        • Yoshida H.
        Local amyloidosis in the hard palate: a case report.
        Oral Maxillofac Surg. 2009; 13: 119-122
        • Reichart P.A.
        • Philipsen H.P.
        Color atlas of dental medicine: oral pathology.
        Thieme Stuttgart, New York2000
        • Elad S.
        • Czerninski R.
        • Fischman S.
        • et al.
        Exceptional oral manifestations of amyloid light chain protein (AL) systemic amyloidosis.
        Amyloid. 2010; 17: 27-31
        • Gouvêa A.F.
        • Ribeiro A.C.
        • León J.E.
        • et al.
        Head and neck amyloidosis: clinicopathological features and immunohistochemical analysis of 14 cases.
        J Oral Pathol Med. 2012; 41: 178-185
      1. Gorevic, PD. Overview of amyloidosis. In: Schur PH, Romain PL, editors. UpToDate. Waltham (MA): UpToDate. Available at: https://www.uptodate.com/contents/overview-of-amyloidosis. Accessed June 12, 2016.

        • Real de Asúa D.
        • Costa R.
        • Galván J.M.
        • et al.
        Systemic AA amyloidosis: epidemiology, diagnosis, and management.
        Clin Epidemiol. 2014; 6: 369-377
        • Kyle R.A.
        • Linos A.
        • Beard C.M.
        • et al.
        Incidence and natural history of primary systemic amyloidosis in Olmsted County, Minnesota, 1950 through 1989.
        Blood. 1992; 79: 1817-1822
        • Kyle R.A.
        • Bayrd E.D.
        Amyloidosis: review of 236 cases.
        Medicine (Baltimore). 1975; 54: 271-299
        • Kerner M.M.
        • Wand M.B.
        • Angier G.
        • et al.
        Amyloidosis of the head and neck. A clinicopathologic study of the UCLA experience 1955-1991.
        Arch Otolaryngol Head Neck Surg. 1995; 121: 778-782
        • Xavier S.D.
        • Bussoloti I.F.
        • Müller H.
        Macroglossia secondary to systemic amyloidosis: case report and literature review.
        Ear Nose Throat J. 2005; 84: 358-361
        • Howie A.J.
        • Brewer D.B.
        • Howell D.
        • et al.
        Physical basis of colors seen in Congo red-stained amyloid in polarized light.
        Lab Invest. 2008; 88: 232-242
        • Pernick N.
        Stains-kappa.
        PathologyOutlines.com, 2015 (Available at:) (Accessed June 16, 2016)
        • Churchill C.H.
        • Abril A.
        • Krishna M.
        • et al.
        Jaw claudication in primary amyloidosis: unusual presentation of a rare disease.
        J Rheumatol. 2003; 30: 2283-2286
        • Matsuda C.
        • Shimizu T.
        • Nakayama Y.
        • et al.
        Macroglossia in advanced amyotrophic lateral sclerosis.
        Muscle Nerve. 2016; 54: 386-390
        • Suresh L.
        • Radfar L.
        Oral sarcoidosis: a review of literature.
        Oral Dis. 2005; 11: 138-145
        • Dastoori M.
        • Fedele S.
        • Leao J.C.
        • et al.
        Sarcoidosis: a clinically orientated review.
        J Oral Pathol Med. 2013; 42: 281-289
        • Govender P.
        • Berman J.
        The diagnosis of sarcoidosis.
        Clin Chest Med. 2015; 36: 585-602
        • Thomas K.W.
        • Hinninghake G.W.
        Sarcoidosis.
        JAMA. 2003; 289: 3300-3303
        • Rybicki B.A.
        • Major M.
        • Popovich Jr., J.
        • et al.
        Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization.
        Am J Epidemiol. 1997; 145: 234-241
        • Du Bois R.M.
        • Goh N.
        • McGrath P.
        • et al.
        Is there a role for microorganisms in the pathogenesis of sarcoidosis?.
        J Intern Med. 2003; 253: 4-17
        • Poate T.W.J.
        • Sharma R.
        • Moutasim K.A.
        • et al.
        Orofacial presentations of sarcoidosis – a case series and review of the literature.
        Br Dent J. 2008; 205: 437-442
        • Hillerdal G.
        • Nöu E.
        • Osterman K.
        • et al.
        Sarcoidosis: epidemiology and prognosis. A 15-year European study.
        Am Rev Respir Dis. 1984; 130: 29-32
        • Marchell R.M.
        • Thiers B.
        • Judson M.A.
        Sarcoidosis.
        in: Wolff K. Goldsmith L. Katz S. Fitzpatrick's dermatology in general medicine. 7th edition. McGraw-Hill, New York2008: 1484-1493
        • Baughman R.P.
        • Lower E.E.
        • du Bois R.M.
        Sarcoidosis.
        Lancet. 2003; 361: 1111-1118
        • Rybicki B.A.
        • Maliarik M.J.
        • Poisson L.M.
        • et al.
        Sarcoidosis and granuloma genes: a family-based study in African-Americans.
        Eur Respir J. 2004; 24: 251-257
        • Motswaledi M.H.
        • Khammissa R.A.G.
        • Jadwat Y.
        • et al.
        Oral sarcoidosis: a case report and review of the literature.
        Aust Dent J. 2014; 59: 389-394
        • Nunes H.
        • Bouvry D.
        • Soler P.
        • et al.
        Sarcoidosis.
        Orphanet J Rare Dis. 2007; 2: 46
        • Darlington P.
        • Tallstedt L.
        • Padyukov L.
        • et al.
        HLA-DRB1* alleles and symptoms associated with Heerfordt's syndrome in sarcoidosis.
        Eur Respir J. 2011; 38: 1151-1157
        • Mana J.
        • Marcoval J.
        • Graells J.
        • et al.
        Cutaneous involvement in sarcoidosis. Relationship to systemic disease.
        Arch Dermatol. 1997; 133: 882-888
        • Giotaki H.
        • Constantopoulus S.H.
        • Papadimimitriou C.S.
        • et al.
        Labial minor salivary gland biopsy: a highly discriminatory diagnostic method between sarcoidosis and Sjögren's syndrome.
        Respiration. 1986; 50: 102-107
        • Nessan V.J.
        • Jacoway J.R.
        Biopsy of minor salivary glands in the diagnosis of sarcoidosis.
        N Engl J Med. 1979; 301: 922-924
        • Drosos A.A.
        • Constantopoulos S.H.
        • Psychos D.
        • et al.
        The forgotten cause of sicca complex; sarcoidosis.
        J Rheumatol. 1989; 16: 1548-1551
        • Sciubba J.J.
        • Said-Al-Naief N.
        Orofacial granulomatosis: presentation, pathology and management of 13 cases.
        J Oral Pathol Med. 2003; 32: 576-585
        • Bouaziz A.
        • Le Scanff J.
        • Chapelon-Abric C.
        • et al.
        Oral involvement in sarcoidosis: report of 12 cases.
        QJM. 2012; 105: 755-767
        • Leavitt R.Y.
        • Fauci A.S.
        • Bloch D.A.
        • et al.
        The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis.
        Arthritis Rheum. 1990; 33: 1101-1107
        • Sung I.Y.
        • Kim Y.M.
        • Cho Y.C.
        • et al.
        Role of gingival manifestation in diagnosis of granulomatosis with polyangiitis (Wegener's granulomatosis).
        J Periodontal Implant Sci. 2015; 45: 247-251
        • Venning M.C.
        • Quinn A.
        • Broomhead V.
        • et al.
        Antibodies directed against neutrophils (c-ANCA and p-ANCA) are of distinct diagnostic value in systemic vasculitis.
        Q J Med. 1990; 77: 1287-1296
        • Savige J.A.
        • Gallicchio M.
        • Georgiou T.
        • et al.
        Diverse target antigens recognized by circulating antibodies in antineutrophil cytoplasm antibody-associated renal vasculitides.
        Clin Exp Immunol. 1990; 82: 238-243
        • Kubaisi B.
        • Samra K.A.
        • Foster C.S.
        Granulomatosis with polyangiitis (Wegener's disease): an updated review of ocular disease manifestations.
        Intractable Rare Dis Res. 2016; 5: 61-69
        • Guidelli G.M.
        • Tenti S.
        • Pascarelli N.A.
        • et al.
        Granulomatosis with polyangiitis and intravenous immunoglobulins: a case series and review of the literature.
        Autoimmun Rev. 2015; 14: 659-664
        • Heckmann M.
        • Holle J.U.
        • Arning L.
        • et al.
        The Wegener's granulomatosis quantitative trait locus on chromosome 6p21. 3 as characterised by tag SNP genotyping.
        Ann Rheum Dis. 2008; 67: 972-979
        • Chung S.A.
        • Xie G.
        • Roshandel D.
        • et al.
        Meta-analysis in granulomatosis with polyangiitis reveals shared susceptibility loci with rheumatoid arthritis.
        Arthritis Rheum. 2012; 64: 3463-3471
        • Jagiello P.
        • Aries P.
        • Arning L.
        • et al.
        The PTPN22 620W allele is a risk factor for Wegener's granulomatosis.
        Arthritis Rheum. 2005; 52: 4039-4043
        • Mahr A.
        • Neogi T.
        • Merkel P.
        Epidemiology of Wegener's granulomatosis: lessons from descriptive studies and analyses of genetic and environmental risk determinants.
        Clin Exp Rheumatol. 2006; 24: S82-S91
        • Lane S.
        • Watts R.
        • Bentham G.
        • et al.
        Are environmental factors important in primary systemic vasculitis? A case-controlled study.
        Arthritis Rheum. 2003; 48: 814-823
        • Stamp L.K.
        • Chapman P.T.
        • Francis J.
        • et al.
        Association between environmental exposures and granulomatosis with polyangiitis in Canterbury, New Zealand.
        Arthritis Res Ther. 2015; 17: 333
        • Tadema H.
        • Heeringa P.
        • Kallenberg C.G.
        Bacterial infections in Wegener's granulomatosis: mechanisms potentially involved in autoimmune pathogenesis.
        Curr Opin Rheumatol. 2011; 23: 366-371
        • Ponniah I.
        • Shaheen A.
        • Shankar K.A.
        • et al.
        Wegener's granulomatosis: the current understanding.
        Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005; 100: 265-270
        • Wojciechowska J.
        • Krajewski W.
        • Krajewski P.
        • et al.
        Granulomatosis with polyangiitis in otolaryngologist practice: a review of current knowledge.
        Clin Exp Otorhinolaryngol. 2016; 9: 8-13
        • Carter L.M.
        • Brizman E.
        Lingual infarction in Wegener's granulomatosis: a case report and review of the literature.
        Head Face Med. 2008; 4: 19
        • Bachymeyer B.
        • Petitjean B.
        • Testart F.
        • et al.
        Lingual necrosis as the presenting sign of Wegener's granulomatosis.
        Clin Exp Dermatol. 2006; 31: 321-322
        • Brooke R.I.
        Wegener's granulomatosis involving the gingiva.
        Br Dent J. 1965; 118: 30-32
        • Edwards M.B.
        • Buckerfield J.P.
        Wegener's granulomatosis: a case with primary mucocutaneous lesions.
        Oral Surg Oral Med Oral Pathol. 1978; 46: 53-63
        • Green I.
        • Szyper-Kravitz M.
        • Shoenfeld Y.
        Parotitis as the presenting symptom of Wegener's granulomatosis: case report and meta-analysis.
        Isr Med Assoc J. 2013; 15: 188-192
        • Stone J.H.
        • Wegener's Granulomatosis Etanercept Trial Research Group
        Limited versus severe Wegener's granulomatosis: baseline data on patients in the Wegener's granulomatosis etanercept trial.
        Arthritis Rheum. 2003; 48: 2299-2309
        • Mulholland G.B.
        • Jeffery C.C.
        • Stija P.
        • et al.
        Immunoglobulin G4-related diseases in the head and neck: a systematic review.
        Head Neck Surg. 2015; 44: 24
        • Lang D.
        • Zwerina J.
        • Pieringer H.
        IgG4-related disease: current challenges and future prospects.
        Ther Clin Risk Manag. 2016; 12: 189-199
        • Uchida K.
        • Masamune A.
        • Shimosegawa T.
        • et al.
        Prevalence of IgG4-related disease in Japan based on nationwide survey in 2009.
        Int J Rheumatol. 2012; 2012: 358371
        • Cheuk W.
        • Tam F.K.
        • Chan A.N.
        • et al.
        Idiopathic cervical fibrosis-a new member of IgG4-related sclerosing diseases: report of 4 cases, 1 complicated by composite lymphoma.
        Am J Surg Pathol. 2010; 34: 1678-1685
        • Melo J.C.
        • Kitsko D.
        • Reyes-Múgica M.
        Pediatric chronic sclerosing sialadenitis: Küttner tumor.
        Pediatr Dev Pathol. 2012; 15: 165-169
        • Hong X.
        • Li W.
        • Su J.Z.
        • et al.
        Internal organ involvement in IgG4-related sialadenitis: a systemic review.
        Chin J Dent Res. 2015; 18: 85-94
        • Nakajima A.
        • Masaki Y.
        • Nakamura T.
        • et al.
        Decreased expression of innate immunity-related genes in peripheral blood mononuclear cells from patients with IgG4-related disease.
        PLoS One. 2015; 10: e0126582
        • Della-Torre E.
        • Lanzillotta M.
        • Doglioni C.
        Immunology of IgG4-related disease.
        Clin Exp Immunol. 2015; 181: 191-206
        • Deshpande V.
        • Zen Y.
        • Chan J.K.
        • et al.
        Consensus statement on the pathology of IgG4-related disease.
        Mod Pathol. 2012; 25: 1181-1192
        • Stone J.H.
        • Zen Y.
        • Deshpande V.
        IgG4-related disease.
        N Engl J Med. 2012; 366: 539-551
        • Albilia J.B.
        • Lam D.K.
        • Blanas N.
        • et al.
        Small mouths…big problems? A review of scleroderma and its oral health implications.
        J Can Dent Assoc. 2007; 73: 831-836
        • Young A.
        • Khanna D.
        Systemic sclerosis: commonly asked questions by rheumatologists.
        J Clin Rheumatol. 2015; 21: 149-155
        • van den Hoogen F.
        • Khanna D.
        • Fransen J.
        • et al.
        2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative.
        Arthritis Rheum. 2013; 65: 2737-2747
        • Mayes M.D.
        Epidemiology of systemic sclerosis and related diseases.
        Curr Opin Rheumatol. 1997; 9: 557-561
        • Dagenais M.
        • MacDonald D.
        • Baron M.
        • et al.
        The Canadian systemic sclerosis oral health study IV: oral radiographic manifestations in systemic sclerosis compared with the general population.
        Oral Surg Oral Med Oral Pathol Oral Radiol. 2015; 120: 104-111
        • Mayes M.D.
        Scleroderma epidemiology.
        Rheum Dis Clin North Am. 2003; 29: 239-254
        • Coll J.
        • Rives A.
        • Grino M.C.
        • et al.
        Prevalence of Sjögren's syndrome in autoimmune diseases.
        Ann Rheum Dis. 1987; 46: 286-289
        • Cipoletti J.F.
        • Buckingham R.B.
        • Barnes E.L.
        • et al.
        Sjögren's syndrome in progressive systemic sclerosis.
        Ann Intern Med. 1977; 87: 535-541
        • Osial Jr., T.A.
        • Whiteside T.L.
        • Buckingham R.B.
        • et al.
        Clinical and serologic study of Sjögren's syndrome in patients with progressive systemic sclerosis.
        Arthritis Rheum. 1983; 26: 500-508
        • Drosos A.A.
        • Andonopoulos A.P.
        • Costopoulos J.S.
        • et al.
        Sjögren's syndrome in progressive systemic sclerosis.
        J Rheumatol. 1988; 15: 965-968
        • Salliot C.
        • Mouthon L.
        • Ardizzone M.
        • et al.
        Sjögren's syndrome is associated with and not secondary to systemic sclerosis.
        Rheumatology (Oxford). 2007; 46: 321-326
        • Eversole L.R.
        • Jacobsen P.L.
        • Stone C.E.
        Oral and gingival changes in systemic sclerosis (scleroderma).
        J Periodontol. 1984; 55: 175-178
        • Elimelech R.
        • Mayer Y.
        • Braun-Moscovici Y.
        • et al.
        Periodontal conditions and tumor necrosis factor-alpha level in gingival crevicular fluid of scleroderma patients.
        Isr Med Assoc J. 2015; 17: 549-553
        • Rout P.G.
        • Hamburger J.
        • Potts A.J.
        Orofacial radiological manifestations of systemic sclerosis.
        Dentomaxillofac Radiol. 1996; 25: 193-196
        • Hopper F.E.
        • Giles A.D.
        Orofacial changes in systemic sclerosis-report of a case of resorption of mandibular angles and zygomatic arches.
        Br J Oral Surg. 1982; 20: 129-134
        • Chu C.H.
        • Yeung C.M.
        • Lai I.A.
        • et al.
        Oral health of Chinese people with systemic sclerosis.
        Clin Oral Investig. 2011; 15: 931-939
        • Haers P.E.
        • Sailer H.F.
        Mandibular resorption due to systemic sclerosis. Case report of surgical correction of a secondary open bite deformity.
        Int J Oral Maxillofac Surg. 1995; 24: 261-267
        • Delantoni A.
        • Matziari E.
        Osteolysis affecting the jaws in systemic sclerosis: clinical and osseous changes based on a case presentation.
        Clin Med Insights Arthritis Musculoskelet Disord. 2015; 18: 65-67
        • Doucet J.C.
        • Morrison A.D.
        Bilateral mandibular condylysis from systemic sclerosis: case report of surgical correction with bilateral total temporomandibular joint replacement.
        Craniomaxillofac Trauma Reconstr. 2011; 4: 11-18
        • Reyes C.M.
        • Rudinskaya A.
        • Kloss R.
        • et al.
        Scleroderma-like illness as a presenting feature of multiple myeloma and amyloidosis.
        J Clin Rheumatol. 2008; 14: 161-165
        • Phumethum V.
        • Jamal S.
        • Johnson S.R.
        Biologic therapy for systemic sclerosis: a systematic review.
        J Rheumatol. 2011; 38: 289-296
        • Young A.
        • Khanna D.
        Systemic sclerosis: a systematic review on therapeutic management from 2011 to 2014.
        Curr Opin Rheumatol. 2015; 27: 241-248
        • Daoussis D.
        • Liossis S.N.
        • Tsamandas A.C.
        • et al.
        Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle study.
        Rheumatology (Oxford). 2010; 49: 271-280
        • Yuen H.K.
        • Weng Y.
        • Bandyopadhyay D.
        • et al.
        Effect of a multi-faceted intervention on gingival health among adults with systemic sclerosis.
        Clin Exp Rheumatol. 2011; 29: S26-S32
        • Shah A.A.
        • Wigley F.M.
        Often forgotten manifestations of systemic sclerosis.
        Rheum Dis Clin North Am. 2008; 34: 221-238
        • Alantar A.
        • Cabane J.
        • Hachulla E.
        • et al.
        Recommendations for the care of oral involvement in patients with systemic sclerosis.
        Arthritis Care Res (Hoboken). 2011; 63: 1126-1133

      Further readings

      Amyloidosis

        • Pau M.
        • Reinbacher K.E.
        • Feichtinger M.
        • et al.
        Surgical treatment of macroglossia caused by systemic primary amyloidosis.
        Int J Oral Maxillofac Surg. 2013; 42: 294-297

      IgG4-related disease

        • Deshpande V.
        IgG4 related disease of the head and neck.
        Head and Neck Pathol. 2015; 9: 24-31
        • Yamamoto M.
        • Takahashi H.
        • Ohara M.
        • et al.
        A new conceptualization for Mikulicz's disease as an IgG4-related plasmacytic disease.
        Mod Rheumatol. 2006; 16: 335-340

      Granulomatosis with polyangiitis

        • Greco A.
        • Marinelli C.
        • Fusconi M.
        • et al.
        Clinic manifestations in granulomatosis with polyangiitis.
        Int J Immunopathol Pharmacol. 2016; 29: 151-159
        • Pakalniskis M.G.
        • Berg A.D.
        • Policeni B.A.
        • et al.
        The many faces of granulomatosis with polyangiitis: a review of the head and neck imaging manifestations.
        AJR Am J Roentgenol. 2015; 205: W619-W629

      Systemic sclerosis (systemic scleroderma) including CREST syndrome

        • Cazal C.
        • Sobral A.P.V.
        • Neves R.F.N.
        • et al.
        Oral complaints in progressive systemic sclerosis: two cases report.
        Med Oral Patol Oral Cir Bucal. 2008; 13: E114-E118